ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Interview

Moderna taps Singapore, Hong Kong for COVID era expansion

Taiwan, Malaysia also picked; CEO Bancel eyes vaccine plants in Asia

Moderna, which developed one of the main COVID-19 vaccines used worldwide, is looking to begin production in Asia. (Source photo by Akira Kodaka and Reuters)

SINGAPORE -- COVID-19 vaccine maker Moderna will expand into Singapore, Hong Kong, Taiwan and Malaysia this year to better serve the Asian market, where its shots continue to be used to battle the coronavirus pandemic.

The Nasdaq-listed company announced its plan on Wednesday but did not disclose how much it was investing to set up offices in those locations to support the expansion, or how many additional people it will be hiring.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more